Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Perrigo Moves In On Major Generic Firms With Agis Acquisition

This article was originally published in The Tan Sheet

Executive Summary

Perrigo's acquisition of Israeli generic drug firm Agis Pharmaceuticals will put the combined entity's annualized sales over the $1 bil. mark and in the same league with major Rx generic drug players
Advertisement

Related Content

Perrigo appointment
Perrigo appointment
Perrigo appointment
Pseudoephedrine 2006 Sales To Decline 35%, Perrigo Projects
Perrigo Predicts Cough/Cold Sales Drop Due To Pseudoephedrine BTC Move
Perrigo-Agis deal
Perrigo To Develop New Products With Bentley
Leiner Loratadine Success In 2004 Positions Firm For Further OTC Growth
Perrigo To Enter Generic Rx Drug Market With OTC Experience In Mind
Perrigo To Enter Generic Rx Drug Market With OTC Experience In Mind

Topics

Advertisement
UsernamePublicRestriction

Register

PS097548

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel